Kardiotonik dori vositalarining klinik farmakologiyasi

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/5390

Full metadata record

DC Field	Value	Language
dc.contributor.author	Sh.A. Saidova., A.V. Yakubov., L. J. Musaeva., D.B. Pulatova., N.I.Pulatova., Sh.S.Aripdjonova	-
dc.date.accessioned	2022-12-20T07:17:22Z	-
dc.date.available	2022-12-20T07:17:22Z	-
dc.date.issued	2022	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/5390	-
dc.description.abstract	Turli xil farmakologik guruhlarga xos dori moddalar yurakning qisqarish kuchini oshirishi mumkin, ya’ni musbat inotrop ta’sirga ega bo‘lgan dori vositalari. Kardiomiotsitlarning qisqarishi kalsiy ionlarining aktin–troponin-tropomiozin kompleksi bilan bog‘langanda sodir bo‘ladi Miokard qisqarish kuchining oshishi kalsiy ionlarining qonsentratsiyasi kardiomiotsitlarda to‘planish tezligini oshishi va qisqaruvchi oqsillarning kalsiy ionlariga sezgirligini oshishi bilan bog‘liq.	en_US
dc.language.iso	other	en_US
dc.publisher	Ўзбекистон, Тошкент	en_US
dc.subject	Kardiotonik dori vositalarining klinik farmakologiyasi	en_US
dc.title	Kardiotonik dori vositalarining klinik farmakologiyasi	en_US
dc.type	Other	en_US
Appears in Collections:	Books and Book Chapters

Files in This Item:

File	Description	Size	Format
ЛотинКардиотоник_ДВ.pdf	Kardiotonik dori vositalarining klinik farmakologiyasi	1.55 MB	Adobe PDF	View/Open

DSpace JSPUI